Research and Markets: US Market Opportunities for Respiratory and Sleep Management Devices 2010-2014

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bc203c/us_market_opportun) has announced the addition of the "US Market Opportunities for Respiratory and Sleep Management Devices 2010-2014" report to their offering.

“US Market Opportunities for Respiratory and Sleep Management Devices 2010-2014”

The US respiratory and sleep management device market is steadily growing. Oxygen therapy is the preferred treatment for chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the US. As the US population ages, COPD is expected to become more prevalent, and thus the market for oxygen therapy will continue to grow, especially for portable oxygen devices. With 80% of obstructive sleep apnea (OSA) sufferers remaining undiagnosed in the US, the OSA testing and therapeutic device market also holds significant potential.

Increased awareness of OSA among both physicians and patients will result in a surge of diagnosis and therapy. With the threat of national health emergencies, such as SARS and, more recently, H1N1, national and state-wide stockpiling of ventilators will continue to drive the ventilator market. This report examines the market potential and competitive landscape of each segment, including detailed analyses of unit sales, average selling prices (ASPs), market revenues, and competitors' market shares.

Questions answered in this report:

In 2009, the Centers for Medicare & Medicaid Services (CMS) announced new reimbursement policies to increase the number of patients being diagnosed with OSA in the US. What is the projected impact of the new CMS reimbursement policies on the therapeutic OSA and sleep diagnostic device markets? How will these new reimbursement rates create opportunities to reach the large undiagnosed patient population in the US? Which competitors are positioned to benefit from these changes?
In 2008, the economic situation in North America caused a credit freeze for many US hospitals, preventing them from purchasing capital equipment. The economy is expected to begin recovering in 2010, and credit is expected to be released. What will be the effect of the economy on capital equipment unit sales? How will the recession affect future purchasing decisions?
The aging population of the US will drive oxygen therapy device sales through 2014. How will this population shift affect oxygen therapy product preference? How will competitors in this market adapt to the unique needs of the aging population?
The trend toward disaster preparedness in the US has lead to stockpiling initiatives of emergency medical equipment and ventilators. How will stockpiling initiatives drive unit sales? How will bulk purchases of ventilators affect ASPs?

Scope:

Regions covered: US

Segmentation: Our analysis uses the following segmentation of the market:

Therapeutic OSA devices:

Continuous positive airway pressure devices
Bi-level positive airway pressure devices
Autotitrating positive airway pressure devices
Masks

Ventilators:

Adult and Pediatric (acute, subacute, and home care)
Neonatal (conventional and high-frequency)
Noninvasive
Transport

Oxygen therapy systems:

Oxygen concentrators (stationary, transfilling, and portable)
Liquid oxygen systems (base and portable)
Oxygen conservers (pneumatic and electronic)
Oxygen regulators

Sleep diagnostic systems:

In-lab polysomnography systems
Home sleep tests (Type II, Type III, and Type IV)

Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in unit sales, ASPs, and market values over a 7-year period (20082014).

Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.

47 Companies Mentioned, Some Include: